A detailed history of D. E. Shaw & Co., Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 345,725 shares of AVNS stock, worth $6.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
345,725
Holding current value
$6.43 Million
% of portfolio
0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.21 - $24.69 $2.71 Million - $3.48 Million
-140,822 Reduced 28.94%
345,725 $8.31 Million
Q2 2024

Aug 14, 2024

BUY
$17.85 - $20.42 $1.33 Million - $1.53 Million
74,767 Added 18.16%
486,547 $9.69 Million
Q1 2024

May 15, 2024

BUY
$17.97 - $22.68 $1.4 Million - $1.76 Million
77,663 Added 23.24%
411,780 $8.2 Million
Q4 2023

Feb 14, 2024

SELL
$17.64 - $22.99 $776,089 - $1.01 Million
-43,996 Reduced 11.64%
334,117 $7.49 Million
Q3 2023

Nov 14, 2023

BUY
$19.93 - $26.31 $170,361 - $224,897
8,548 Added 2.31%
378,113 $7.65 Million
Q2 2023

Aug 14, 2023

SELL
$22.53 - $30.98 $3.33 Million - $4.58 Million
-147,816 Reduced 28.57%
369,565 $9.45 Million
Q1 2023

May 15, 2023

SELL
$26.92 - $31.75 $2.66 Million - $3.13 Million
-98,641 Reduced 16.01%
517,381 $15.4 Million
Q4 2022

Feb 14, 2023

SELL
$19.88 - $27.37 $2.05 Million - $2.82 Million
-102,999 Reduced 14.32%
616,022 $16.7 Million
Q3 2022

Nov 14, 2022

SELL
$21.56 - $29.59 $1.33 Million - $1.82 Million
-61,613 Reduced 7.89%
719,021 $15.7 Million
Q2 2022

Aug 15, 2022

SELL
$24.87 - $34.68 $2.91 Million - $4.05 Million
-116,815 Reduced 13.02%
780,634 $21.3 Million
Q1 2022

May 16, 2022

BUY
$28.87 - $35.77 $3.59 Million - $4.44 Million
124,254 Added 16.07%
897,449 $30.1 Million
Q4 2021

Feb 14, 2022

BUY
$29.25 - $36.02 $2.08 Million - $2.56 Million
70,960 Added 10.1%
773,195 $26.8 Million
Q3 2021

Nov 15, 2021

BUY
$31.2 - $38.5 $5.85 Million - $7.22 Million
187,548 Added 36.44%
702,235 $21.9 Million
Q2 2021

Aug 16, 2021

BUY
$36.37 - $45.72 $11.6 Million - $14.6 Million
320,127 Added 164.54%
514,687 $18.7 Million
Q1 2021

May 17, 2021

BUY
$43.5 - $53.4 $1.11 Million - $1.37 Million
25,620 Added 15.17%
194,560 $8.51 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $49.5 $2.47 Million - $3.69 Million
-74,638 Reduced 30.64%
168,940 $7.75 Million
Q3 2020

Nov 16, 2020

SELL
$28.67 - $34.32 $1.71 Million - $2.05 Million
-59,790 Reduced 19.71%
243,578 $8.09 Million
Q2 2020

Aug 14, 2020

BUY
$23.48 - $33.86 $1.6 Million - $2.31 Million
68,287 Added 29.05%
303,368 $8.92 Million
Q1 2020

May 15, 2020

BUY
$20.64 - $34.41 $2.97 Million - $4.96 Million
144,048 Added 158.24%
235,081 $6.33 Million
Q4 2019

Feb 14, 2020

SELL
$31.89 - $47.34 $5.37 Million - $7.98 Million
-168,543 Reduced 64.93%
91,033 $3.07 Million
Q3 2019

Nov 14, 2019

BUY
$32.06 - $44.0 $584,710 - $802,472
18,238 Added 7.56%
259,576 $9.72 Million
Q2 2019

Aug 14, 2019

SELL
$37.68 - $46.52 $5.51 Million - $6.8 Million
-146,265 Reduced 37.74%
241,338 $10.5 Million
Q1 2019

May 15, 2019

BUY
$39.84 - $51.04 $1.65 Million - $2.12 Million
41,508 Added 11.99%
387,603 $16.5 Million
Q4 2018

Feb 14, 2019

BUY
$41.16 - $66.67 $11.5 Million - $18.6 Million
279,054 Added 416.24%
346,095 $15.5 Million
Q3 2018

Nov 14, 2018

BUY
$55.13 - $72.65 $3.7 Million - $4.87 Million
67,041 New
67,041 $4.59 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $865M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.